See also this year's filing and all EDGAR filings for this company.
PDF Report 0001385818_2023_AYTU_BIOPHARMA_INC.pdf
Logs
Graph
Absolute values for 0001385818, AYTU BIOPHARMA INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 59,929,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 70,632,000 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 7,062,000 |
4 | LiabilitiesCurrent | 64,442,000 |
5 | LiabilitiesNoncurrent | 12,810,000 |
6 | remainder_Liabilities | 14,279,000 |
7 | CostOfGoodsAndServicesSold | 44,386,000 |
8 | SellingGeneralAndAdministrativeExpense | 31,167,000 |
9 | ResearchAndDevelopmentExpense | 14,439,000 |
10 | remainder_Expenses | 118,128,000 |
11 | remainder_Revenues | 96,669,000 |
12 | remainder_NetIncome | 1,278,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 137,623,000 |
1 | Liabilities | 91,531,000 |
2 | Expenses | 208,120,000 |
3 | Revenues | 96,669,000 |
4 | StockholdersEquity | 46,092,000 |
5 | NetIncome | -110,173,000 |
6 | ComprehensiveNetIncome | -110,173,000 |
7 | BaseVar | 267,610,500 |
8 | EconomicCapitalRatio | -0.270 |